###
中国临床研究:2026,39(1):17-21
本文二维码信息
码上扫一扫!
益生菌干预胰岛素抵抗的研究进展
(1. 杭州师范大学公共卫生学院预防医学系, 浙江 杭州 311121;2. 兰溪市人民医院, 浙江 兰溪 321100;3. 浙江大学医学院附属妇产科医院 浙江省子宫恶性肿瘤诊治中心, 浙江 杭州 310006)
Research progress of probiotics intervention in insulin resistance
摘要
本文已被:浏览 230次   下载 158
投稿时间:2025-05-24   网络发布日期:2026-01-27
中文摘要: 胰岛素抵抗(IR)是指机体对胰岛素敏感性下降的一种病理状态,由此引起的糖脂代谢紊乱可导致2型糖尿病、冠心病、代谢综合征等多种慢性疾病。IR的发病机制较为复杂,而随着研究深入,许多证据表明,肠道微生物可以通过调控机体能量代谢和炎症反应影响 IR 的发生发展。益生菌不仅能够调节肠道菌群、影响能量摄入,还能通过激活免疫应答促进机体健康。因此,通过益生菌来调节肠道菌群进而干预IR的发生,引发了越来越多的关注。本文围绕IR的发病机制、肠道菌群尤其是益生菌调节影响IR的相关机制作一综述。
Abstract:Insulin resistance(IR)refers to a pathological condition in which the body’s sensitivity to insulin decreases. The resulting disorders of glucose and lipid metabolism can lead to the onset and progression of various chronic diseases,such as type 2 diabetes mellitus(T2DM),coronary heart disease,metabolic syndrome,etc. The pathogenesis of IR is complex,but with in-depth research,accumulating evidence has suggested that gut microbiota can affect the development and progression of IR by regulating energy metabolism and inflammatory responses. Probiotics not only regulate gut microbiota and impact energy intake,but also promote health by activating immune responses. Therefore,the use of probiotics to modulate gut microbiota and intervene in the development of IR has garnered increasing attention. This review summarizes the current research advancements regarding the pathogenesis of IR,as well as the related mechanisms by which gut microbiota,especially probiotics,affect IR.
文章编号:     中图分类号:R587.1    文献标志码:A
基金项目:浙江省自然科学基金委-华东医药联合基金重点项目(LHDMZ24H040001)
附件
引用文本:
徐婷,韩金邑,许可欣,等.益生菌干预胰岛素抵抗的研究进展[J].中国临床研究,2026,39(1):17-21.

用微信扫一扫

用微信扫一扫